Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy

被引:23
作者
Maron, MS
Zenovich, AG
Casey, SA
Link, MS
Udelson, JE
Aeppli, DM
Maron, BJ
机构
[1] Tufts Univ, New England Med Ctr, Div Cardiol, Hypertroph Cardiomyopathy Ctr, Boston, MA 02111 USA
[2] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN USA
[3] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN USA
关键词
D O I
10.1016/j.amjcard.2005.01.077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In hypertrophic cardiomyopathy (HC) an important subgroup of patients develop progressive and disabling symptoms that are related to heart failure and death. Although a direct relation has been demonstrated between left ventricular (LV) wall thickness and likelihood of sudden and unexpected death (usually in patients who are asymptomatic or mildly symptomatic), it is unresolved whether magnitude of hypertrophy is similarly associated with severity of heart failure. To determine the relation of LV wall thickness to heart failure symptoms in HC, 700 consecutive patients who had HC were assessed by 2-dimensional echocardiography. The relation between maximum level of heart failure symptoms by New York Heart Association functional class and maximum LV wall thickness was not linear but rather parabolic. Therefore, marked symptoms were most commonly associated with moderate degrees of LV hypertrophy (wall thickness 16 to 24 mm; 27%) but less frequently with extreme hypertrophy (>= 30 mm 13%) or mild hypertrophy (<= 15 mm; 19%, p = 0.0001). Mean New York Heart Association functional class showed a similar pattern with respect to moderate hypertrophy (1.9 +/- 0.8), mild hypertrophy (1.6 +/- 0.9), and extreme hypertrophy (1.6 +/- 0.7, p = 0.005). Multivariable regression analysis showed the parabolic relation between heart failure symptoms and magnitude of LV hypertrophy to be independent of other hypertrophic cardiomyopathy related clinical variables. In conclusion, no direct relation was evident between symptoms of heart failure and magnitude of LV wall thickness, with implications for the natural history of HC. (c) 2005 by Excerpta Medica Inc.
引用
收藏
页码:1329 / 1333
页数:5
相关论文
共 31 条
[1]   REGIONAL LEFT-VENTRICULAR MECHANICS IN HYPERTROPHIC CARDIOMYOPATHY [J].
BETOCCHI, S ;
HESS, OM ;
LOSI, MA ;
NONOGI, H ;
KRAYENBUEHL, HP .
CIRCULATION, 1993, 88 (05) :2206-2214
[2]   EFFECTS OF VERAPAMIL ON LEFT-VENTRICULAR SYSTOLIC FUNCTION AND DIASTOLIC FILLING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY [J].
BONOW, RO ;
ROSING, DR ;
BACHARACH, SL ;
GREEN, MV ;
KENT, KM ;
LIPSON, LC ;
MARON, BJ ;
LEON, MB ;
EPSTEIN, SE .
CIRCULATION, 1981, 64 (04) :787-796
[3]   Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function [J].
Briguori, C ;
Betocchi, S ;
Romano, M ;
Manganelli, F ;
Losi, MA ;
Ciampi, Q ;
Gottilla, R ;
Lombardi, R ;
Condorelli, M ;
Chiariello, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (03) :309-315
[4]   MECHANISMS OF EXERCISE LIMITATION IN HYPERTROPHIC CARDIOMYOPATHY [J].
CHIKAMORI, T ;
COUNIHAN, PJ ;
DOI, YL ;
TAKATA, J ;
STEWART, JT ;
FRENNEAUX, MP ;
MCKENNA, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (03) :507-512
[5]   Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy [J].
Elliott, PM ;
Blanes, JRG ;
Mahon, NG ;
Poloniecki, JD ;
McKenna, WJ .
LANCET, 2001, 357 (9254) :420-424
[6]   Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients [J].
Elliott, PM ;
Poloniecki, J ;
Dickie, S ;
Sharma, S ;
Monserrat, L ;
Varnava, A ;
Mahon, NG ;
McKenna, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2212-2218
[7]   DETERMINANTS OF EXERCISE CAPACITY IN HYPERTROPHIC CARDIOMYOPATHY [J].
FRENNEAUX, MP ;
PORTER, A ;
CAFORIO, ALP ;
ODAWARA, H ;
COUNIHAN, PJ ;
MCKENNA, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (07) :1521-1526
[8]   PHENOTYPIC SPECTRUM AND PATTERNS OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTROPHIC CARDIOMYOPATHY - MORPHOLOGIC OBSERVATIONS AND SIGNIFICANCE AS ASSESSED BY 2-DIMENSIONAL ECHOCARDIOGRAPHY IN 600 PATIENTS [J].
KLUES, HG ;
SCHIFFERS, A ;
MARON, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (07) :1699-1708
[9]   EXERCISE CAPACITY IN HYPERTROPHIC CARDIOMYOPATHY - ROLE OF STROKE VOLUME LIMITATION, HEART-RATE, AND DIASTOLIC FILLING CHARACTERISTICS [J].
LELE, SS ;
THOMSON, HL ;
SEO, H ;
BELENKIE, I ;
MCKENNA, WJ ;
FRENNEAUX, MP .
CIRCULATION, 1995, 92 (10) :2886-2894
[10]   Hypertrophic cardiomyopathy - A systematic review [J].
Maron, BJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10) :1308-1320